Previous Page  16 / 19 Next Page
Information
Show Menu
Previous Page 16 / 19 Next Page
Page Background

Notes:

Page 42

Gastroenterology 2016

September 12-14, 2016

Volume 6, Issue 5(Suppl)

J Gastrointest Dig Syst 2016

ISSN:2161-069X JGDS, an open access journal

conferenceseries

.com

September 12-14, 2016 Atlanta, USA

7

th

Global Congress on

Gastroenterology & Endoscopy

Screening vs. diagnostic colonoscopy: First time colon cancer screening in an inner city tertiary care

hospital

David Bamshad, Joshua Jackson, Jared Okun, Snow Nguyen

and

Maryam Khan

New York Medical College, USA

T

he United States Preventive Services Task Force (USPSTF) recommends a screening colonoscopy for all average risk

patients aged 50-75. Nonetheless, it remains the second leading cause of death related to cancer in the United States, and

the third most common type of cancer overall. These statistics are represented disproportionately, as minority populations

maintain a greater degree of incidence and mortality. A retrospective review at a major inner city teaching hospital was

performed. Average risk first time screening colonoscopies over a 2-month period were analyzed. 122 charts were identified.

Ages of males to females and African Americans (AA’s) were compared to Non-AA’s. In addition, the percentage of patients

that underwent a screening colonoscopy only once experiencing gastrointestinal related symptoms was analyzed. The average

first time screening age for average risk AA’s (n =70) was 59.34. Non-AA’s (n=25) had an average age of 59.76. The average

male (n=42) was 59.86 while the average female (n=53) was aged 59.38. The percentage of patients that only underwent

a colonoscopy once symptomatic was 22.13% (n = 27). Disparities between the USPSTF screening recommendations and

the observed age among patients in an inner city hospital were identified . It illustrates the number of patients that only

underwent a screening colonoscopy once they had gastrointestinal complaints. It questions the presence of cancer prevention

conversations between physicians and patients in an inner city community, and emphasizes the staggering number of patients

that are brought into the fold of screening behaviors either late altogether or because of incidental symptoms.

Biography

Joshua Jackson recieved his MD from St. Georges University School of Medicine. He has also completed a Master’s in Science. He is currently a resident of

Internal Medicine at Brookdale University Medical Center in Brooklyn, NY. He has presented his work at major national conferences across the United States. His

main academic focus is on health disparities and patient advocacy in medicine.

jaredmokun@gmail.com

David Bamshad et al., J Gastrointest Dig Syst 2016, 6:5(Suppl)

http://dx.doi.org/10.4172/2161-069X.C1.037